2023: Patent Alert! The US Patent Office has just issued a new patent to DNA Polymerase Technology! The patent was awarded for Taq D732N, a single mutant of Taq that can catalyze RT-PCR, RT-LAMP, faster PCR, and improved PCR for food safety. We have commercialized the product under our trade name, OmniTaq 2. https://patents.google.com/patent/US11814655B2/en?oq=11%2c814%2c655
For more details on this invention, see our refereed paper, A single amino acid change to Taq DNA polymerase enables faster PCR, reverse transcription and strand displacement. WM Barnes, Z Zhang, MB Kermekchiev - Frontiers in Bioengineering and Biotechnology, 2021
2020: Klentaq1 aids in development of bisulfite PCR-LDR-qPCR assay for breast cancer detection.
2019: Vanderbilt Researchers detect SNP markers for antimalarial resistance using OmniTaq 3.
2017 and 2019: OmniKlentaq LA aids in the development of Long-Adapter Single-Strand Oligonucleotide (LASSO) probes: 2017 and 2019.
2015: National Institute of Justice Success Story: Addressing a Key Challenge for PCR-Based Forensic Tests
2014: Lab-on-a-chip technology for Malaria detection from whole blood using OmniKlentaq and PEC-1
2013: OmniKlentaq-LA beats out 8 other PCR enzymes on old bones
2008: DNA Polymerase Technology's scientist, Dr. Milko Kermekchiev, named Inventor of the Year. Meet St. Louis Bar Association 2008 inventor of the year.
2002: "Small lab graduates from incubator to building with space enough to share"